RE:RE:RE:RE:RE:Viemed 1st Quarter 2021 compared to 2022I was rushed yesterday, and want to explain more. What I am trying to say there is no correlation between the stock price and how the company is doing. I think this happened because the stock kept on moving up on increased revenue and then it dropped hard do to Covid, Panic Selling, OIG (total nonsense), and a few other things.
In 2021 we added 111 new employees. In 2022 we added 66 so far, and its only June. Revenues and employees are growing.
Viemed is buying back 2 Million shares cheap on a low EBITA. The buyback can't be over yet with the number of shares traded.
As I always said before these guys would not spend money unless it makes sense.